Literature DB >> 10508251

Human peripheral blood contains two distinct lineages of dendritic cells.

S P Robinson1, S Patterson, N English, D Davies, S C Knight, C D Reid.   

Abstract

Human peripheral blood contains two populations of dendritic cells (DC) but their developmental relationship has not been established. Freshly isolated CD11c- DC possessed a lymphoid morphology, lacked myeloid markers but expressed lymphoid markers (CD4+ CD10+) whilst the CD11c+ DC were monocytoid in appearance and expressed myeloid markers. Although both populations were allostimulatory, only the CD11c+ DC were able to take up antigen. Irrespective of the culture conditions the CD11c- cells developed into CD11c- CD13- CD33- CD4+ CD1a- CD83+/- DC. In contrast, cultured CD11c+ cells developed the phenotype CD11c+ CD13+ CD33+/- CD4- CD1a+ CD83+ CD9+. Only the CD11c+ DC expressed macrophage colony-stimulating factor (M-CSF) receptor and gave rise to CD14+, esterase+, phagocytic macrophages when cultured in M-CSF. These data suggest that these two populations of DC represent distinct lineages of antigen-presenting DC.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10508251     DOI: 10.1002/(SICI)1521-4141(199909)29:09<2769::AID-IMMU2769>3.0.CO;2-2

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  71 in total

1.  Phenotypic characterization of five dendritic cell subsets in human tonsils.

Authors:  K L Summers; B D Hock; J L McKenzie; D N Hart
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

2.  Plasmacytoid dendritic cells are highly susceptible to human immunodeficiency virus type 1 infection and release infectious virus.

Authors:  S Patterson; A Rae; N Hockey; J Gilmour; F Gotch
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

3.  Elevated expression of CCR5 by myeloid (CD11c+) blood dendritic cells in multiple sclerosis and acute optic neuritis.

Authors:  M Pashenkov; N Teleshova; M Kouwenhoven; V Kostulas; Y-M Huang; M Soderstrom; H Link
Journal:  Clin Exp Immunol       Date:  2002-03       Impact factor: 4.330

4.  The role of pDC, recipient T(reg) and donor T(reg) in HSC engraftment: Mechanisms of facilitation.

Authors:  Paul A Cardenas; Yiming Huang; Suzanne T Ildstad
Journal:  Chimerism       Date:  2011-07-01

5.  Elevated serum interleukin (IL)-12p40 levels in common variable immunodeficiency disease and decreased peripheral blood dendritic cells: analysis of IL-12p40 and interferon-gamma gene.

Authors:  N Martinez-Pomar; S Raga; J Ferrer; J Pons; I Munoz-Saa; M-R Julia; J de Gracia; N Matamoros
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

6.  Regulation of host innate immunity by hepatitis C virus: crosstalk between hepatocyte and NK/DC.

Authors:  Sung-Jae Park; Young S Hahn
Journal:  Rev Infect       Date:  2010-07-01

7.  Direct ex vivo analysis of dendritic cells in patients with hepatocellular carcinoma.

Authors:  Lars-A Ormandy; Anatol Farber; Tobias Cantz; Susanne Petrykowska; Heiner Wedemeyer; Monique Horning; Frank Lehner; Michael-P Manns; Firouzeh Korangy; Tim-F Greten
Journal:  World J Gastroenterol       Date:  2006-05-28       Impact factor: 5.742

Review 8.  Airway Macrophage and Dendritic Cell Subsets in the Resting Human Lung.

Authors:  Vineet Indrajit Patel; Jordan Patrick Metcalf
Journal:  Crit Rev Immunol       Date:  2018       Impact factor: 2.214

9.  Dendritic Cell Recovery Impacts Outcomes after Umbilical Cord Blood and Sibling Donor Transplantation for Hematologic Malignancies.

Authors:  Waseem Touma; Claudio G Brunstein; Qing Cao; Jeffrey S Miller; Julie Curtsinger; Michael R Verneris; Veronika Bachanova
Journal:  Biol Blood Marrow Transplant       Date:  2017-07-17       Impact factor: 5.742

10.  Nonstructural proteins 1 and 2 of respiratory syncytial virus suppress maturation of human dendritic cells.

Authors:  Shirin Munir; Cyril Le Nouen; Cindy Luongo; Ursula J Buchholz; Peter L Collins; Alexander Bukreyev
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.